Market Research Blog – Page 5999 – Just another WordPress site

Smart Insulin Pens Market is projected to post massive gains, expanding at a staggering double digit CAGR through 2031

ESOMAR-certified consulting firm Future Market Insights (FMI) projects the global smart insulin pens market is likely to surpass the billion dollar mark by 2021, expanding at a positive CAGR, as per a newly published research report. A stupendous double digit growth rate has been predicted for the market in the long-run. Growing preference for non-invasive treatment and the ever widening diabetes burden are likely to steer the market in a forward direction.

According to FMI’s report, the market posted significant gains in the past, with Bluetooth smart insulin pens generating over 30% of the revenue share in 2017. Also, according to the International Diabetes Federation, presently, just under half a billion people are living with diabetes worldwide, and their number is projected to increase by 25% in 2030, and 51% by 2045 respectively.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1827

Manufacturers, therefore, are leveraging these trends to introduce novel and innovative product lines, enabling them to secure a firm footing in the market. In November 2020, for instance, Medtronic launched its InPen^TMsmart insulin device equipped with real-time Guardian^TMConnect CGM Data- the first smart insulin pen for diabetics on multiple daily injections. Recently, in April 2021, BioCorp and Roche Diabetes Care launched the Mallya smart insulin pen device in France.

Key Takeaways from FMI’s Smart Insulin Pens Market Report

By connectivity, Bluetooth connected smart insulin pens to account for over half of the revenue share by 2031
By indication, type 2 diabetes treatment to account for the bulk of smart insulin pens deployment
Retail pharmacies were the primary distribution channels for smart insulin pens, e-commerce sales spiking rapidly
US to experience credible growth amid increasing approval rates for new diabetes management devices
Growing preference for needle-free insulin injections to widen adoption across the UK
Germany & France to experience increased collaborations between key manufacturers in the long-run
Large concentration of regional level manufacturers to pivot growth across India and China

Smart Insulin Pens Market – Key questions answered in the report

What trends are in store for the smart insulin pens market growth?
According to FMI, the global smart insulin pens market is likely to register a multi-billion dollar valuation in the short and long-run forecasts, attributed to a general increase in the global diabetic population pool and the consequent increase in hospital workload. Demand for Bluetooth connected smart insulin pens is expected to remain especially high
Which is the most promising smart insulin pens market?
As per FMI’s analysis, demand for smart insulin pens are expected to remain high across the US market, attributed to unceasing efforts by the government to eradicate the diabetes epidemic by virtue of extensive advertising campaigns. Additionally, India and China are expected to emerge as the dominant markets in the Asia-Pacific region, characterized by the presence of numerous regional level manufacturers

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1827

Which prominent players operate in the global smart insulin pens market?

Digital Medics Pty Ltd.,
Emperra GmbH e-Health Technologies,
Companion Medical Inc.,
Sanofi Aventis LLC,
Novo Nordisk A/S,
Eli Lily and Company,
Companion Medical,
Diabnext,
Jiangsu Delfu Medical Device Co. Ltd.,
DIAMESCO Co Ltd.,
Patients Pending Ltd (Bigfoot Biomedical Inc.),
BERLIN-CHEMIE

are some major smart insulin pens manufacturers profiled in FMI’s report

Competitive Landscape

Major insulin pens manufacturers are effectively leveraging major expansion strategies, ranging from new product launches and R&D to collaborating with existing manufacturers or outright/partial acquisition of key market players. A major emphasis is being laid on incorporating virtual technological advancements to enhance diabetes management.

In February 2021, Novo Nordisk and the University of Toronto announced a CAD 40 million investment deal to establish the Novo Nordisk Network for Healthy Populations. This network will focus on new approaches to address diabetes and aid in chronic disease prevention. This will likely help broaden smart insulin pens development.

Companies are also focusing on providing advanced software platforms, such as Digital Medics’ DiabetesPlus DataSync Software. This platform enables users to download insulin and glucose data directly from the device. Key features include downloading insulin data from the insulin pen, glucose levels from the glucose meter and synchronization of data on the Cloud for use with mobile devices.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1827

According to FMI’s report, the following insulin pens manufacturers currently operate in the global market:

Digital Medics Pty Ltd.
Emperra GmbH e-Health Technologies
Companion Medical Inc.
Sanofi Aventis LLC
Novo Nordisk A/S
Eli Lily and Company
Diabnext
Jiangsu Delfu Medical Device Co. Ltd.
DIAMESCO Co Ltd.
Patients Pending Ltd (Bigfoot Biomedical Inc.)
BERLIN-CHEMIE

Smart Insulin Pens Market – Key Segments Covered

Indication

Diabetes Type I
Diabetes Type II

Connectivity

Bluetooth Connected
USB Connected

Distribution Channel

Clinics & Ambulatory Surgical Centers
E-Commerce
Retail Pharmacies

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

Oncology Information Systems Market Volume : The oncology information systems market is projected to be worth US$ 2.59 Bn by 2022 and is expected to grow to US$5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.

Biomaterials Market Demand : The global biomaterials market is expected to reach a market valuation of US$ 156.2 Billion by the year 2022, accelerating with a moderate CAGR of 15.4% by 2022-2032.

IoT in Healthcare Market Size : The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Vision Care Market is projected to be valued at US$ 169.37 B by 2032 | FMI

[340 Pages Report] The global vision care market is valued at US$ 83.72 billion in 2022. The market is expected to be valued at US$ 169.37 billion by 2032. The CAGR is expected to be 7.3% during the forecast period.

Since the past decade, there has been an increase in the usage of electronic devices. The more time we spend in front of the screen, the more our eyes get exposed to the rays emitted from the devices. This in turn starts affecting our eyes, and we start adopting various types of vision care products.

Additionally, we are living at times when the people working in large corporate houses hardly have any time to prepare food by themselves. Because of this they start consuming fast foods, which are believed to be unhealthy.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-822

Therefore, the eyes are not able to receive the required nutrients. This has led to an increase in the demand for vision care products.

Moreover, there have been tremendous improvements in the logistics and supply chain management, as a result of which the vision care products can be transported from any part of the globe.

However, if there is one segment which has significantly contributed to the growth of vision care market it is the geriatric population. With age, the eye lens become rigid, which leads to different kinds of eye problems. Thus, the increased requirement by geriatric population is expected to increase the sales of vision care products.

Moreover, there have been increased initiatives taken by the government and other ruling authorities to increase the awareness of vision care devices.

Key Takeaways:

The vision care market is expected to grow at a CAGR of 7.3% during the forecast period.
The vision care market is expected to be valued at US$ 169.37 billion by 2032.
The vision care market is valued at US$ 83.72 billion as on 2022.
Based on the product type, the spectacle lens segment is the most preferred segment in the vision care market.
Based on the type, the non-prescription mode is expected to surge the market for vision care devices.
Based on the channel, the retail hypermarket/superstore is the most preferred in the vision care market.
North America is projected to be the largest market based on regional insights.
Asia Pacific is the second largest, and the fastest growing vision care market.
Based on country analysis, USA vision care market the largest market, with a share of nearly 34% in North America, and is expected to grow at a CAGR of 7.5% during the forecast period.
India market is expected to grow at a CAGR of 9.4% during the forecast period.
Chinese vision care market is anticipated to grow at a CAGR of 7.1%

Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-822

Competitive Landscape

With a view to increase their footprints across the nations, the major players are getting involved in mergers and acquisitions which would drive their business to new heights.

Some of the recent developments are:

In July 2022, Bausch and Lomb enrolled first patient in LASIK clinical trial, thereby evaluating the use of Technolas TENEO Excimer Laser for vision correction surgery for hyperobia.
In February 2022, Johnson and Johnson was named a 2022 Fortune world’s most admired company and ranked #1 on the pharmaceutical industry list.

Key Companies Profiled

Bausch and Lomb (Acq. by Valeant Pharmaceuticals)
Alcon (sub. Novartis AG)
CooperVision
Johnson & Johnson
LUXOTTICA GROUP
Essilor
ZEISS International
Safilo Group
Rodenstock.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-822

Key Segments in the Vision Care Market

By Product Type:

Spectacle Lenses
Contact Lenses
Cleaning & Disinfecting Solutions

By Type:

Rx (Prescription)
Non-Rx (Non-prescription)

By Distribution Channel:

Hospitals
Ophthalmic Clinics
Optometry Stores
E-Commerce
Retail Hypermarket/Superstore

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

edical Drones Market Sales : The medical drones market is anticipated to flourish in the worldwide market at a strong CAGR of 24.3% during the forecast period, reaching a revenue of US$ 280.6 Mn in 2022

Liquid Biopsy Market Forecast : Global liquid biopsy market demand is anticipated to be valued at US$ 1,146 Million in 2022, forecast a CAGR of 13.49% to be valued at US$ 4,126 Million from 2022 to 2032.

Digital Patient Monitoring Systems Market Value : The global Digital Patient Monitoring Systems market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032.

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Workout Clothes Market Worth US$ 384.8 Billion by 2032: Future Market Insights, Inc.

The workout clothes market was valued at US$ 210.8 Billion in 2022 and is predicted to reach US$ 384.8 Billion by 2032, growing at a CAGR of 6.2% through 2032.

Workout clothes are a type of utility clothing that improves athletes’ performance during sports or fitness physical activities by enhancing body movement compared to ordinary clothing.

Furthermore, unique benefits of sportswear, such as breathability, rapid drying, static resistance, heat resistance, and chemical resistance, increase consumer acceptance, hence pushing the workout clothes market growth and workout clothes adoption trends.

Request Sample Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-14750

Adopting the same is expected to influence potential workout clothes market trends and forecasts positively.

The worldwide workout clothes market key trends & opportunities are expanding due to buyers’ rising disposable income and fitness consciousness.

The Coronavirus epidemic has had a detrimental influence on the workout clothes market since lockdowns and limitations on the number of customer store occupancy have resulted in a decrease in sales of workout clothes.

The growing popularity of smart sportswear, which is meant to improve training routines, monitor performance, and offer real-time feedback, represents a workout clothes market growth potential.

Due to the significant demand for workout clothes to engage in fitness or sports activities, the others (shorts, sweatshirts & hoodies, tank-top) segment produced the most income.

However, the workout clothes market is predicted to rise rapidly as the trend of athleisure as casual wear among the world’s youth population grows.

Polyester sector workout clothes market share is rising due to several benefits like fast-drying, enough stretch capacity, easy wash, wrinkle resistance, and chemical resistance.

Use promo code ->> FMITODAY to get flat 30% discount

Furthermore, increased physical activity engagement among the young and senior population drives demand for workout clothes, boosting workout clothes market future trends and workout clothes market opportunities.

However, an increase in the number of counterfeit items is causing consumer safety and quality difficulties and brand harm for important workout clothes market participants and workout clothes market share.

The United States is predicted to emerge as a significant region in the workout clothes market due to the increased demand for workout clothes. With the expanding number of public athletic events, Europe and the Asia Pacific are also projected to add to income and surge workout clothes market opportunities.

Key Takeaways:

The others (shorts, sweatshirts & hoodies, tank-top) section from the product type segment of the workout clothes market is expected to grow at a CAGR of 4% through 2032.
Polyester segment will escalate in the workout clothes market’s material type sector through 2032.
United States dominated the global workout clothes market, accounting for 42.3% of total sales.
The rise in disposable income and rising living standards are likely to drive the growth of the LAMEA workout clothes market.
Due to the popularity of sporting events, the European workout clothes market is expanding at a rapid pace.
Asia-Pacific is predicted to develop at the fastest rate due to an increase in youth engagement in sporting activities.

Competitive Landscape:

Adidas AG, Asics Corporation, Columbia Sportswear Company, Dick’s Sporting Goods, Inc. Gap Inc., Nike, Inc., North Face, Inc., Phillips-Van Heusen Corporation, Puma Se, and Under Armour, Inc. are among the major legacy players that provide workout clothes solutions.

To increase their products in the workout clothes market trends, these vendors have used a variety of organic and inorganic growth techniques, such as new product releases, partnerships, and collaborations.

To extend their influence in the workout clothes market trends, these vendors have used a variety of organic and inorganic growth tactics.

Ask to Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-14750

Recent Development in the Workout clothes Market:

Product Launch:

Global sports brand PUMA debuted the Royal Challenger Bangalore (RCB) workout clothes market collection in September 2021 as part of a three-year strategic collaboration agreement agreed with the franchise in March 2021.
Eastbay and Champs Sports announced the debut of a new garment line, Eastbay Performance, in September 2021.
Puma SE Inc announced the introduction of its sportswear range in collaboration with Cloud9 in October 2019.

Collaboration:

Kappa and Hyosung announced their collaboration in October 2020 to launch Kappa’s new K-Spirit e-sports workout clothes collection at the Tennent Global E-Sports Arena (TGA).

Acquisition:

Nike announced the purchase of Collect, a workout clothes statistics and demand sensing start-up located in Boston in August 2019.

Segments

By Product Type:

Shirts
Pants
Others (Shorts, Sweatshirts & Hoodies, Tank-Top),

By Consumer Orientation:

Men
Women
Children

By Material Type:

Nylon
Wool
Polyester
Others

By Sales Channel:

Direct Sales
Franchised Stores
Specialty Stores
Online Retailers
Other Sales Channel (Mono Brand Stores, Wholesalers/Retailers)

By Region:

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Get 40% Discount on Customized Report@
https://www.futuremarketinsights.com/customization-available/rep-gb-14750

About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Wearable Sleep Trackers Market is expected to expand at a CAGR of 7.8% from 2022 – 2028

[265 Pages Report] The global Wearable Sleep Trackers Market is anticipated to generate US$ 3.1 Bn in revenue by the end of 2028, growing at a CAGR of 7.8% over the forecast period. Over the course of the forecast period, the Asia-Pacific wearable sleep tracker market is anticipated to rise significantly at a CAGR of around 11%.

The global wearable sleep tracker market is segmented based on product type, application, distribution channel and regions. Based on product type, the global wearable sleep tracker market is segmented into wearable sleep tracker ring devices, wearable sleep tracker wristband and hand band devices, wearable sleep tracker headband devices and sleep mask tracker devices. The wearable ring devices is expected to be the leading segment in the global wearable sleep tracker market, and is projected to grow at a CAGR of 9.5% over the forecast period.

Based on application type, the global wearable sleep tracker market is segmented into insomnia, sleep apnea and others. The others segment (including wellness application) in the global wearable sleep tracker market is expected to account a high revenue share and grow at a CAGR of 7.1% over the forecast period. Based on distribution channel, the global wearable sleep tracker market is segmented into pharmacy and retails stores, online sales, hypermarkets and supermarkets and others. The online sales in the global wearable sleep tracker market is expected to be the leading segment, and is expected to grow at a CAGR of 7.9% over the forecast period.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6007

The growth of the global wearable sleep tracker market is primarily driven by increasing incidence of sleep disorders such as insomnia and sleep apnoea globally, availability of different types of wearable sleep trackers and growing awareness regarding sleep-related ailments and importance of a healthy sleep. Likewise, the number of new cases of sleep disorders have increased globally owing to the rise in obese and geriatric population and increase in unhealthy habits leading to unhealthy lifestyle. Different types of wearable sleep tracker devices are present in the market with different price ranges and fitness requirements. Besides, awareness regarding healthy sleep is also growing due to several educational programs and availability of information on the internet on conditions such as insomnia and sleep apnoea. Several sleep foundations such as the National Sleep Foundation are consistently spreading awareness regarding sleep disorder symptoms, diagnosis and treatments available.

There is a consistent growth in the healthcare expenditure in developed regions such as North America, Western Europe and Japan owing to increased incidence and prevalence of health-related problems and sleep disorders. Besides, growth in disposable income has contributed to an increase in wellness penetration, which has led to the growth of the market for wearable sleep tracker. Improved wearable sleep tracker technologies and better aesthetics are also expected to drive the growth of the wearable sleep trackers market over the forecast period.

Any Queries, Speak To Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6007

This report assesses the trends that are driving the growth of each segment of the wearable sleep tracker market on the global as well as regional level, and offers potential takeaways that could prove substantially useful to the manufacturers planning to enter the wearable sleep tracker market.

North America accounted a high revenue share in 2017 and is expected to be the dominant regional market for wearable sleep tracker over the forecast period. The U.S. wearable sleep tracker market is expected to hold a large share in North America and is expected to grow at a CAGR of 5.1% over the forecast period. China and Asia Pacific excluding China & Japan wearable sleep tracker markets are anticipate to exhibits with double digit CAGRs over the forecast period.

Examples of some of the key players covered in the report of the wearable sleep tracker market are Fitbit, Inc., Garmin Ltd., Koninklijke Philips N.V., Huami Corporation, Fossil Group, Inc., and Huawei Technologies Co., Ltd., among others. The companies are focusing on developing novel wearable technologies. However, the higher cost associated with certain wearable sleep trackers and lack of standardization of these devices might hinder the growth of the wearable sleep trackers market over the forecast period.

In this report, we have discussed the individual strategies followed by these companies regarding the improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report has been concluded with the key takeaways of the players present in the market and the new players planning to enter the market.

Buy Industry Research Report: https://www.futuremarketinsights.com/checkout/6007

Wearable Sleep Tracker Market by Category

By Product:

Wearable Ring Devices
Wearable Wrist and Hand band Devices
Wearable Headband Devices
Sleep Mask Tracker Devices

By Application:

Insomnia
Sleep Apnea
Others

By End User:

Pharmacy and Retail Stores
Online Sales
Hypermarkets and Supermarkets
Others

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Medical Cleaning Devices Market Growth : The global Medical cleaning devices market is expected to reach a market valuation of US$ 21.5 Billion by the year 2022.

Immunoassay Market Size : The global immunoassay market is expected to be worth USD 45.78 billion by 2032, growing at a CAGR of 5% from its current value of USD 29.51 billion in 2022.

Humanized Mouse Model Market Trends : The global humanized mouse model market is expected to be valued at US$ 92.5 Million in 2022. Throughout the decade spanning 2022-2032

About FMI:

Animal Model Market is projected to reach US$ 2.4 Bn by 2028 | FMI

The global Animal Model Market is estimated to be valued at US$ 1.7 Bn in 2022, and is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028.

According to a recently compiled study by Future Market Insights, the global Animal Model Market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end.

Animal Model Market Size (2022)	US$ 1.7 Bn
Sales Forecast (2028)	US$ 2.4 Bn
Global Market Growth Rate (2022 to 2028)	6.6% CAGR
Share of Top 5 Animal Model Suppliers	50%

Leveraging Animal Models offers Better Understanding of Different Diseases

Animals and human beings share a common biological as well as physiological structure. Animals possess shorter life cycle, however they have high genotype resemblance. It is simple and easy to control the animal environment as compared to the human beings.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-3141

Key Takeaways from FMI’s Report on Global Animal Model Market

North America is expected to remain the largest and fastest expanding market for animal model, with revenues estimated to surpass US$ 800 Mn by 2026-end. Between animal model markets in Asia-Pacific and Europe, the former will account for relatively larger revenue share, whereas the latter will expand at a comparatively higher CAGR through 2026. Although the market in South Korea will account for the lowest market revenue share, revenues are projected to expand at a relatively higher CAGR than those from the markets in Latin America and Middle East & Africa (MEA) through 2026.

On the basis of species, revenues from rats and mice are projected to account for over two-fifth share of the market by 2026-end. Revenues from use of rats in animal models will expand at the highest CAGR in the market through 2026. In addition, revenues from use of cats and monkeys in animal models will rise at a nearly equal CAGR through 2026. Dogs and pigs are expected to remain the least lucrative species used in animal models during the forecast period.

Contract research organizations (CROs) and biotechnology companies are anticipated to remain the fast expanding end-users of animal models. Revenues from these two end-users are collectively forecast to surpass US$ 850 Mn by 2026-end. In terms of revenues, academic & research institutions and pharmaceutical companies will continue to be dominant end-users in the global animal model market.

Basic and applied research application of animal model will continue to register the fastest expansion through 2026. However, drug discovery/development will remain the most lucrative application of animal model.

Key companies actively contributing to growth of the global animal model market include Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc., Trans Genic Inc, The Jackson Laboratory, Horizon Discovery Group plc, and Charles River Laboratories International, Inc.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3141

Key Segments of Animal Model Industry Research

Animal Model Market by Species:

Rats
Mice
Guinea Pigs
Rabbits
Monkeys
Dogs
Pigs
Cats
Other Species

Animal Model Market by End User:

Academic & Research Institutions
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Other End Users

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-3141

Animal Model Market by Application:

Basic and Applied Research
Drug Discovery/Development

Animal Model Market by Region:

North America Animal Model Market
Latin America Animal Model Market
Europe Animal Model Market
East Asia Animal Model Market
South Asia & Pacific Animal Model Market
Middle East & Africa (MEA) Animal Model Market

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Demand for analgesics in Europe is expected to register growth at 5.3% CAGR over the next ten years | FMI

[318 Pages Report] As per Future Market Insights’ revised industry analysis, the global analgesics market was valued at over US$ 73.6 Bn in 2020, and is expected to exhibit a CAGR of 5.6% over the forecast period (2021-2031).

Analgesics encompasses a class of drugs that are designed to relieve pain. Different classes of analgesic drugs include opioids, NSAIDs, local anesthetics, and acetaminophen. Analgesics can be administered by various routes such as oral, IV, rectal, topical, and others.

Increasing number of patients suffering from chronic conditions such as cancer, chronic pulmonary obstructive disease (COPD), as well as increase in post-operative pain management prescription medications and various trauma conditions leading to pain are expected to boost the analgesics market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Various companies are prioritizing strategic collaborations for the development of non-opioid-based analgesics and an integrated approach towards pain management, prevention of diversion of prescription opioid medications, and the signs of potential abuse or addiction associated with opioid medications.

According to WHO, worldwide, about 0.5 million deaths are attributable to drug use. More than 70% of these deaths are related to opioids, with more than 30% of those deaths caused by overdose. This is a key challenge to the market.

Pfizer is developing non-opioid drugs in partnership with Eli Lilly, and in 2017 Pfizer announced its plans to donate 1 million doses of Naloxone hydrochloride injections to direct relief over four years (up to 250,000 doses per year). This initiative helped to promote the use of non-opioid analgesics for pain management.

Key Takeaways from Market Study

By drug class opioids are expected to hold 49.3% market value share by the end of 2031, primarily because of their efficacy in intense pain relief.
Based on indication, surgical pain is leading with over 45.9% market share in 2020, owing to rising number of surgical procedures conducted globally.
Based on route of administration, oral route holds a dominant share of 37.9% in the global analgesics market.
Hospital pharmacies dominated analgesics market with a share of 32.8% in 2020.
By region, Europe is slated to be the second-largest leading market with a value share of 25.0% by the end of the forecast period.

“Rising prevalence of chronic and neuropathic pain and development of non-addictive formulations will drive the sales of analgesics over the forecast period” says a FMI analyst.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1306

Competitive Landscape

Acquisitions, mergers, expansion strategies, and product launches are often adopted by manufacturers to gain competitive edge. Some of them are focusing on the development of novel formulations of non-opioid drugs. Besides this, expansion in high potential market will remain key strategy among market players to strengthen their footprint. For instance:

In July 2020, Teva Pharmaceuticals decided to expand its operations in the Japan market by focusing on specialty assets and a portfolio of select generics to meet patients’ medical needs.
In September 2021, Bausch Health Companies Inc. and its gastroenterology business,Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021. RELISTOR® (methylnaltrexone bromide) is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Analgesics market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the drug class (opioids, NSAIDs, local anaesthetics and acetaminophen), indication (surgical pain, cancer pain, neuropathic pain and others), route of administration (oral, parenteral, transdermal and others), distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies), across seven key regions of the world.

Future Market Insight’s Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

Key Market Segments Covered in Analgesics Market ResearchBy Drug Class:

Opioids
- Morphine
- Codiene
- Fentanyl
- Meperidine
- Methadone
- Tramadol
- Oxycodone
- Dextromethorphan
- Buprenorphine
- Others
NSAIDs
Local Anesthetics
Acetaminophen

By Indication:

Surgical pain
Cancer Pain
Neuropathic pain
Others

By Route of Administration:

Oral
Parenteral
Transdermal
Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1306

By Distribution Channel:

Hospital pharmacies
Retail pharmacies
Drug Stores
Online pharmacies

More Trending Reports by Future Market Research:

Biomaterials Market Demand : The global biomaterials market is expected to reach a market valuation of US$ 156.2 Billion by the year 2022, accelerating with a moderate CAGR of 15.4% by 2022-2032.

IoT in Healthcare Market Size : The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032.

Robotic Wheelchair Market Share : The global demand for the robotic wheelchair market is set to witness growth at 11.5% CAGR from 2022 to 2032, surpassing US$ 127.1 Mn in 2022.

About FMI:

Future Market Insights The medical rehabilitation robotics market is expected to reach US$ 1.4 Bn by 2031

[406 Pages Report] As per a recent market analysis by Future Market Insights (FMI), the global medical rehabilitation robotics market was valued at over US$ 264.0 Mn in 2020 and is projected to expand at a stupendous 15.9% CAGR over the forecast period.

Increasing development of robotic products and devices that have the ability to perform a wide array of tasks is propelling sales in the market. Surgical robots are developed for the purpose of assisting surgeons in operating on a varied range of procedures, which in turn is improving patient outcomes.

The designing and development of automated robotic models for rehabilitation and assistive services and applications have led to an advancement in disease recovery term. Rising awareness regarding the use of medical rehabilitation robotics for patients with disabilities, as well as for cognitive and behavioral disorders is spurring demand in the market.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14242

The growth in rehabilitation therapy and integrated robotics has increased research and development activities associated with their applications in home-based settings. In comparison with clinical therapy, home therapy has the potential to augment standard care and enable a consistent treatment regime by increasing the frequency and duration of training sessions.

Carrying out rehabilitation services at home offers convenience and comfort. Growing preference for affordable, convenient, and time-saving robotic devices over other therapy devices in hospitals settings is expected to augment the growth of the market.

The development of medical rehabilitation robotics market is reliant on increasing healthcare spending, rising research and development activities, larger government-backed funding, and rising initiatives to promote the utility of rehabilitation robots

Key Takeaways:

Based on product type, demand in the therapeutic/assistive products is expected to account for 71.8% of the total market share in 2031, growing at a 15.4% CAGR.
In terms of extremity, the upper extremity segment is expected to hold 54.8%of the total market share by 2031.
Sales in the limb motility segment are projected to grow at a 15.9% CAGR through 2031.
In terms of patient type, the adults segment held 86.9% of the total market share in 2020, and the trend is expected to continue over the forecast period.
Applications in the neurorehabilitation segment are projected to account for a substantial share in the global medical rehabilitation robotics market.
Rehabilitation centers held the largest value share of 47.7% in 2020. However, hospitals are expected to account for 36.9% of the total market share by 2031.

“The integration of automation and assistive technology in medical equipment, along with surging demand for artificial intelligence (AI) based robotics in rehabilitation centers will continue boosting the market over the forecast period,” says an FMI analyst.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14242

Competition Landscape

Leading players operating in the market are investing in acquisitions, mergers, expansion, and the development of an extensive clinical pipeline to improve sales in the market. Besides this, players are expandingtheir product portfolios to increase their consumer base. For instance:

In October 2021, Fourier Intelligence was selected and awarded the Top 4 Leading Rehabilitation Technology Enterprise by KPMG and the China Association of Non-Public Health Institutions, co-organized by the Health Sector Strategy at an event that was held in Shanghai.
In December 2020, Anthrtonix DANA, a telehealth tool by AnthroTronix, was used at the Johns Hopkins Hospital to identify and monitor cognitive deficits and recovery of COVID-19 patients.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the medical rehabilitation robotics market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the Product – (Exoskeletons and Therapeutic/ Assistive), Extremity- (Upper Extremity and Lower Extremity), Therapy Type (Limb Mobility, Gait and Sensory), Patient Type (Adult and Paediatric), Application (Neurorehabilitation, Physical Rehabilitation and Others) and End User (Hospitals, Wellness Centers, Rehabilitation Centers and Homecare) across seven key regions of the world.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14242

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Medical Rehabilitation Robotics Market By Category

Product:

Exoskeletons
Therapeutic/ Assistive

Therapy Type:

Limb Mobility
Gait
Sensory

Extremity:

Upper Extremity
Lower Extremity

Patient Type:

Adults
Paediatric

Application:

Neurorehabilitation
Physical Rehabilitation
Others

End User:

Hospitals
Wellness Centers
Rehabilitation Centers
Homecare

About FMI:

The Acetaminophen Market in South Korea is likely to expand at a CAGR of 4.5% during the forecast period | FMI

[332 Pages Report] According to a recent study by Future Market Insights (FMI), the global acetaminophen market is expected to grow from US$ 9.4 Bn in 2021, to over US$ 14.1 Bn by 2031, expanding at a 4.1% CAGR over the forecast period 2021-2031.

Acetaminophen/ paracetamol is widely being adopted by individuals and healthcare providers and are sold over the counter, which is boosting sales in the market. Paracetamol is widely consumed as it is suitable to all age groups i.e. adults, children’s, pediatrics and geriatrics to treat mild to moderate pain. Paracetamol is the most efficient and safe drug to manage pain when consumed in a controlled dosage.

The most prescribed OTC (over the counter) drug is acetaminophen, which is widely used as the first line of treatment. As chronic disorders have symptoms of pain, demand is projected to increase over the forecast period.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14325

According to the CDC, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities. Similarly, in the U.K., around 26% of patients with diabetes were found to have peripheral neuropathic pain. Paracetamol can be combined with other pain management drugs that are sold through prescription only, which is expected to continue boosting sales.

Further, increasing awareness regarding palliative care in terminally ill patients is boosting the adoption of analgesics for pain management. Since the prevalence of pain is over 75% in advanced disease conditions, sales are expected to gain traction in the forthcoming years.

In the U.S., palliative care services are delivered following government and commercial reimbursement policies. Hospital palliative care programs in the U.S. include palliative care consultation teams and dedicated in-patient care units. Non-hospital palliative care programs include ambulatory care, and office and home-based palliative care programs.

Healthcare companies are collaborating with healthcare professionals, healthcare service providers, and hospitals to improve quality care for the patients. In addition to this, manufacturers are investing in product development to improve sales in the market. For instance, in 2020, Haihe Pharmaceutical Co. Ltd. outsourced the China rights to its non-opioid analgesic candidates, RMX-1001 and RMX-1002, to 3D Biomedicine Science & Technology Co. Ltd.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14325

Key Takeaways:

Based on product type, the acetaminophen segment is projected to growt at a 4.1% CAGR through 2031.
The oral route of administration segment accounted for 92.4% of the total market share in 2021.
In terms of sales type, the OTC (over the counter) segment accounted for 91.6% of the global market share in 2021.
Sales through retail pharmacies will continue gaining traction. In 2021, the segment accounted for 28.5% of the total market share.
North America held the largest share of 33.0% of the global acetaminophen market in 2021, and the trend is expected to continue over the assessment period.

“Growing demand for self-aid and cost-effective OTC pain relievers, along with increasing usage of acetaminophen as the first line of treatment for pain management are the key factors projected to drive the market in the forthcoming years,” says the FMI analyst.

Competition Landscape

Leading players operating in the global acetaminophen market are Abbott, Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Bristol-Myers Squibb and Company, Cardinal Health Inc., Viatris, Procter & Gamble Company, Sanofi, Novartis AG, Bayer AG, Teva Pharmaceutical Industries Ltd, Perrigo Company, Mallinckrodt Pharmaceuticals, Glaxo SmithKline Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Sun Pharmaceutical Industries Ltd.

Some of the leading companies of the acetaminophen market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence. For instance:

Johnson & Johnson, In March 2020, announced that it will be boosting up production of its flagship product Tylenol which is an over-the-counter pain killer
GlaxoSmithKline, In February 2020 was approval by the Food and Drug Administration for Advil Dual Action, with acetaminophen as an over-the-counter (OTC) product for pain relief.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/14325

More Insights into Acetaminophen Market Report

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global acetaminophen market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the acetaminophen market. The Market is segmented into four parts based on product (acetaminophen, acetaminophen with opioids, others) based on the route of administration (oral, injectable, others) based on sales type (OTC (over the counter) and RX (prescription) based on the distribution channel (hospital pharmacies, retail pharmacies, drug stores, e-commerce, others) and across seven major regions.

Acetaminophen Market By Category Product Type :

Acetaminophen
Acetaminophen with Opioids
Others

Route of Administration :

Oral
Injectable
Others

Sales Type :

OTC (Over-the-counter)
Rx (Prescription)

Distribution Channel :

Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-commerce
Others

About FMI:

Automated CPR Devices Market Analysis, Recent Trends and Regional Growth Forecast by 2031

The demand for automated CPR devices has been increasing significantly with rising prevalence of sudden cardiac arrest across the globe, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated CPR devices market is slated to grow at approximately 13% CAGR throughout the forecast period from 2021 to 2031.

The market is anticipated to grow significantly over the forthcoming decade, as majority of coronary and intensive care units are inclining towards automated CPR devices for its high effectiveness.

Major progress has been witnessed with 3D automatic CPR devices, especially when normal CPR device coupled with torso restraints providing vertical compression and high quality resuscitation.

Automated CPR devices experienced a surge in demand during the Covid-19 pandemic. COVID-19 infected heart patients were more susceptible to cardiac arrest in comparison with non infected patients. With rapid mutation of virus, the patients were facing higher risk of cardiac arrest.

“Rising consumer awareness regarding benefits of CPR devices and increasing adoption in EMT services will amplify sales of automated CPR devices during the forecast period,” says the FMI analyst.

Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-720

Key Takeaways from FMI’s Automated CPR Devices Market Study

Presence of modern healthcare infrastructure and high per capita income will bolster demand across the U.S.
The U.K is expected to offer growth opportunities as governments and private organizations are working towards spreading awareness regarding dangers of cardiovascular diseases.
Rising prevalence of obesity and high blood pressure which are precursor to cardiac arrest will increase automated CPR devices adoption across France.
China will offer lucrative opportunities owing to increasing alcohol and tobacco consumption and developing healthcare infrastructure.
India is expected to exhibit impressive market growth owing to increase in geriatric population and growing incidence of sudden cardiac arrest in the country.

Competitive Landscape

Automated CPR market is highly consolidated owing to presence of regional and global market players. Key market players in automated CPR devices market are focusing towards employing inorganic market strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting. New market entrants are focusing on new product launches to establish their market presence.

For instance, Michigan Instruments launched hand-free automatic CPR device which is light weight, portable and helps in smooth transition from manual CPR to automated compressions.

ZOLL Medical Corporation introduced a new automated CPR devices system “Autopulse” which assists EMS personnel in providing high quality chest compressions in cramped spaces and steep down stairwells.

Prominent players operating in the automated CPR devices market are SunLife Science Inc., ZOLL Medical Corporation, Michigan Instruments, Physio Control Inc., Brunswick Biomedical Technologies, Zhuhai Kindway Medical Science & Technology Co. Ltd, CPR Medical Devices Inc., and Medtronic Inc.

In its latest report, FMI offers an unbiased analysis of the global automated CPR devices market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of power source (pneumatically driven CPR devices, battery driven CPR devices, and mechanically actuated and battery driven CPR device), device type (piston devices, load distribution devices, and 3D compression devices) and end user for (Ems, hospitals, ambulances, coronary & intensive care units, cardiac catheterization labs, air med-evac units, and EMT rescue units) across North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-720

Key Segments Covered

By Power Source

Pneumatically Driven CPR Devices
Battery Driven CPR Devices
Mechanically Actuated And Battery Driven CPR Device

By Device Type

Piston Devices
Load Distribution Devices
3D Compression Devices

By End User

EMS
Hospitals
Ambulances
Coronary & Intensive Care Units
Cardiac Catheterization Labs
Air Med-Evac Units
EMT Rescue Units
Others

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain:

Lab Accessories Market is anticipated to register a CAGR of 6.8% during the period of 2022-2032. The market is anticipated to reach US$ 1.1 Billion in 2032, from US$ 585.0 Million in 2022

Nuclear Medicine Equipment Market is expected to have a steady CAGR of 4.1% during the period 2022-2032

Contraceptives Market is expected to reach a valuation of US$ 18 Bn in 2022. Demand for contraceptive drugs and devices is slated to surge at a 5.5% CAGR, with the total market size reaching US$ 30.8 Bn by 2032

About FMI:

Dental Adhesives Market is projected to enjoy a valuation of US$ 2.31 Bn by 2022

[250 Pages Report] According to the forecast, Japan will hold the largest market during the forecast period. Changing lifestyles, a growing geriatric population, and increasing occurrence of dental decay are expected to lead to market growth in the region. Increasing health awareness in Japan will provide better growth opportunities for dental adhesives in the market. Social media trends and high capital investments required for cosmetic dental treatments are expected to continue to contribute to the growth of the market in Japan for dental adhesives in the near future.

As clinics and hospitals have mushroomed in recent years, particularly in emerging markets, advanced technologies have been rapidly adopted in dentistry, and the clinic clientele has grown, the large share can be attributed to these factors. Further, dental adhesives are expected to become increasingly popular as the demand for cosmetic dentistry and restorative procedures increases.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15784

One of the major factors driving the growth of the dental adhesive market is the rise in the prevalence of dental disorders around the world. The dental adhesive market will also experience profitable growth between 2022 and 2032 as adhesive systems and procedures continue to innovate in the market. Increasing social media usage and growing beauty consciousness is expected to increase demand for celebrity smiles, thereby facilitating market growth for dental adhesives in Japan.

Furthermore, this region is expected to see growth in the dental adhesives market due to increased investment in research and development and the need for more affordable, comfortable dental adhesives in the market. As disposable incomes continue to grow, and as government initiatives to promote dental adhesives and FDA-approved adhesives continue to be implemented, the market is likely to grow even further.

A number of dental advancements have contributed to dental advancements in Japan, but age-related tooth loss remains a concern. About 58% of adults worldwide are expected to be edentulous. With a growing number of elderly people becoming edentulous, the need for dentures will increase. The retention, comfort, and efficiency of complete dentures can often be a source of frustration for denture wearers. As a result, dental adhesives in Japan will grow and their usage will increase in the forecast years.

In addition, the increased costs of dental fees caused by Russia’s invasion of Ukraine have led to a rising trend in the cost of dental care, which will negatively impact the growth of dental adhesives in the region.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15784

Key Takeaways

According to the estimates, Japan will continue to dominate the East Asia dental adhesives sector with an estimated market share of 34.3%.
The global market for restoration adhesives is expected to hold 65.7% of the market share by 2022.
Dental adhesives will reach a market value of US$ 2.31 billion by 2022.
The market for dental adhesives will grow in the future with the development of liquid and gel formulations.
Resin-based direct adhesive restorations with remineralizing agents are expected to grow with growing advances.

Competitive Landscape

The companies are adapting their business models to fit the new normal, transforming manual operations into digital ones, and making investments in artificial intelligence and robotic treatments, since these methods are becoming more and more prevalent in the modern world. Furthermore, through the forecast period, top players in the global dental adhesives market are expected to acquire new technology through mergers and acquisitions.

Recent Developments

With Nexus RMGI, Kerr Dental has relaunched a resin-modified antimicrobial luting cement incorporating Smart Response Ion Technology. NexusTM RMGI, the first RMGI with advanced NexusTM Technology, provides sustained ion release to help prevent secondary caries, easy cleanup, outstanding bond strength, and good color stability. Besides offering ease of use, recent studies show that the NexusTM RMGI also helps to prevent secondary caries with sustained ion release.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15784

Key Market Segments Covered in Dental Adhesives Industry Research

By Product:

Denture Adhesives
Restorative Adhesives

By Formulation:

Creams
Powders
Liquid
Others

By Distributional Channel:

Dental Clinics
Hospitals
Dental Academic and Research Institutes
Others

Explore Other Reports Links From Healthcare Market:

Women Digital Health Solutions Market is estimated at US$ 2.3 Bn in 2022 and is projected to reach a valuation of US$ 20.1 Bn by 2032, expanding at a CAGR of 24.2% through the forecast period of 2022-2032

Cardiac Assist Devices Market: is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Bn by 2031.

Digital Patient Monitoring Systems Market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032

About FMI: